Task A68: Screening Vaccine (and Other Biologics) Platform Technologies using Coronavirus Mouse Immunogenicity as a Model System
$563,541N01FY2022AINIH
Univ Of North Carolina Chapel Hill, Chapel Hill NC
Investigators
Abstract
This contract provides for the development and standardization of small animal models of infectious diseases, and may include efficacy testing of candidate products, including GLP studies to support licensure.
View original record on NIH RePORTER →